Showing results (521-530 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|September 3, 2021
Characterization of Non-Small-Cell Lung Cancers With MET Exon 14 Skipping Alterations Detected in Tissue or Liquid: Clinicogenomics and Real-World Treatment PatternsJessica K Lee, Russell Madison, Anthony Classon, et al.
JCO Precision Oncology|August 12, 2021
TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional RecurrenceYao Yu, Dan Fan, Xinmao Song, et al.
JCO Precision Oncology|May 26, 2021
Phase I/II Study of Capmatinib Plus Erlotinib in Patients With MET-Positive Non-Small-Cell Lung CancerCaroline E McCoach, Aiming Yu, David R Gandara, et al.
JCO Precision Oncology|May 26, 2021
Impact of ALK Inhibitors in Patients With ALK-Rearranged Nonlung Solid TumorsYuki Takeyasu, Hitomi S Okuma, Yuki Kojima, et al.
JCO Precision Oncology|May 26, 2021
Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy and Bevacizumab in HER2-Negative Breast CancersMads H Haugen, Ole Christian Lingjærde, Ingrid Hedenfalk, et al.
JCO Precision Oncology|May 26, 2021
GPS Assay Association With Long-Term Cancer Outcomes: Twenty-Year Risk of Distant Metastasis and Prostate Cancer-Specific MortalityMichael A Brooks, Lewis Thomas, Cristina Magi-Galluzzi, et al.
JCO Precision Oncology|January 30, 2023
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 TrialEric Pujade-Lauraine, Jessica Brown, Alan Barnicle, et al.
JCO Precision Oncology|February 14, 2023
Clinicogenomic Landscape of Metastatic Thymic Epithelial TumorsFatemeh Ardeshir-Larijani, Bryan P Schneider, Sandra K Althouse, et al.
JCO Precision Oncology|February 8, 2023
Olaparib in Patients With Metastatic Prostate Cancer With BRCA1/2 Mutation: Results From the TAPUR StudyEddy S Yang, Susan Halabi, Michael Rothe, et al.
JCO Precision Oncology|February 27, 2023
Plasma and Urine Free Glycosaminoglycans as Monitoring and Predictive Biomarkers in Metastatic Renal Cell Carcinoma: A Prospective Cohort StudyFrancesco Gatto, Sinisa Bratulic, Eric Jonasch, et al.
Pageof 140